Jing Wang, MD, PhD

Jing Wang

Jing Wang, MD, is a researcher at National Jewish Health. Dr. Wang is in the Department of Biomedical Research.

Research AreasResearch Areas
  • Basic Immunology
  • Cancer
  • Cellular and Molecular Biology
  • Molecular Immunology

Special Interests

Research Interests

Genomic instability and cancer development: Internal or external insults can cause chromosomal breaks. Incorrect juxtaposition of different pieces of chromosomes during the repair process leads to chromosomal translocation, which can promote cancer. Cancer type-specific translocations are frequently identified in leukemia and lymphomas, and increasingly found in solid tumors. However, the mechanisms underlying the generation and specificity of translocations are poorly understood.  Our goal is to understand the molecular mechanisms that promote translocations and cancer development in B lymphocytes. We are investigating how DNA double strand breaks (DSBs) response factors suppress oncogenic translocations. Furthermore, we are elucidating how cancer-type specific translocations are generated at the molecular level, and how mechanistic factors including DSB frequency, spatial proximity of target loci and DNA repair pathways influence translocation frequency and spectrum.

Tumor cells evolve two distinct features, unlimited growth and metastasis, which are the major causes for cancerous patient mortality. Our interests focus on how tumor cells acquire the ability to metastasize. Metastasis is a complicated process that includes multiple steps of tumor cells detaching from primary lesion, entering, circulating and exiting from blood or lymphatic vessels, and eventually localizing and growing in distal organs. We hypothesize that genomic instability induced by an uncharacterized somatic mutation process in cancer cells may lead to oncogene activation, which in turn endows tumor cells with metastatic potential.  We are interested in identifying the molecular pathways that initiate the mutational process and contribute to tumor cell metastasis. Our current project is to investigate whether aberrant expression of some cell adhesion molecules in certain types of tumor cells is caused by genomic instability.  We are also studying whether and how these cell adhesion molecules function in tumor metastasis.

Molecular mechanism of somatic hypermutation and class switch recombination: In responses to antigen, activated B cells undergo somatic hypermutation (SHM) and class switch recombination (CSR) to enhance antibody diversity and specificity. Both SHM and CSR require activation induced deaminase (AID). AID causes point mutations in the variable regions of the immunoglobulin (Ig) genes. These mutations lead to increased antibody affinity for specific antigens. AID induces DSBs in the repetitive switch regions of the Ig heavy chain locus to mediate CSR.  CSR assigns antigen-appropriate effector functions to antibody molecules. We are interested in elucidating the molecular mechanisms that regulate AID targeting specificity and efficiency.  Furthermore, AID-initiated DSBs can lead to chromosomal breaks and translocations if they are not properly repaired.  Thus, we are also investigating how AID contributes to genomic instability and cancer development in B cells.


University of Chicago, PhD, Pathology
Ohio State University, MS, Molecular Genetics
Beijing Medical University, MD
Immune Disease Institute,
Children’s Hospital Boston,
Harvard Medical School, Postdoctoral Fellow

Awards & Recognition

2005-2008: Leukemia and lymphoma society (LLS) senior fellowship
1996-1997: Distinguished University Fellowship, Ohio State University
1996: GuangHua Scholarship, Beijing Medical University


Wang JH, Gostissa M, Yan CT, Goff P, Hickernell T, Hansen E, Difilippantonio S, Wesemann DR, Zarrin AA, Rajewsky K, Nussenzweig A, Alt FW (2009). Mechanisms Promoting Translocations in Editing and Switching Peripheral B Cells. Nature, 460(7252), 231-6. News and Views published on Nature.

Wang JH, Alt FW, Gostissa M, Datta A, Murphy M, Alimzhanov MB, Coakley KM, Rajewsky K, Manis JP, Yan CT (2008). Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching. Journal of Experimental Medicine, 205(13), 3079-90. Commentary published on Cell.

Wang J and Fu Y-X (2005). TNF family members and inflammatory bowel disease. Invited Review. Immunological Review 204, 144-155.

Wang J, Anders R A, Wu Q, Peng D, Cho J H, Sun Y, Karaliukas R, Kang H S, Turner J R, Fu Y-X (2004). Dysregulated LIGHT expression on T Cells mediates intestinal inflammation and contributes to IgA nephropathy. Journal of Clinical Investigation, 113, 826-835.

Wang J, Lo J C, Foster A, Yu P, Chen H M, Wang Y, Tamada K, Chen L, and Fu Y-X (2001). The regulation of T cell homeostasis and autoimmunity by T cell derived LIGHT. Journal of Clinical Investigation, 108, 1771-1780. Commentary published on Journal of Clinical Investigation.

Academic Affiliations

Assistant Professor, University of Colorado Denver

Ask a Question through Patient Portal

Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account

Contact Information

  • Office: 877.225.5654



  • National Jewish Health Main Campus
    1400 Jackson St.
    Denver, CO 80206

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.


Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.